Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Gavi

- PMLiVE

Russia becomes first country to approve a COVID-19 vaccine

Vaccine approved after less than two months of human testing

- PMLiVE

US pays $1.5bn for 100 million doses of Moderna’s COVID-19 vaccine

Latest deal is part of Operation Warp Speed

- PMLiVE

Novavax plans to meet US COVID-19 vaccine demand in 2021

Company plans to produce two billion doses if vaccine proves effective

- PMLiVE

J&J inks $1bn deal with US for coronavirus vaccine

Agreement includes manufacturing and delivery of 100 million doses

- PMLiVE

Novavax reports promising phase 1 results for coronavirus vaccine

Candidate induced immune response in early-stage clinical trial

- PMLiVE

AbbVie, Amgen and Takeda team up for joint COVID-19 trial

Collaborative trial will evaluate three anti-inflammatory drugs

- PMLiVE

Eli Lilly begins COVID-19 prevention trial in nursing homes

Trial will investigate monoclonal antibody in up to 2,400 participants

- PMLiVE

NeuroRx, Relief Therapeutics’ COVID-19 drug demonstrates early potential

Drug produced rapid recovery in critically-ill patients

- PMLiVE

UK will provide millions of 90-minute COVID-19 tests over the coming months

Tests will be rolled out ahead of the winter months

- PMLiVE

US secures 100 million doses of Sanofi/GSK’s COVID-19 vaccine

Both companies are also in talks with EU for access to candidate

- PMLiVE

J&J’s COVID-19 vaccine generates positive pre-clinical results

Experimental vaccine begins first-in-human trial this month

- PMLiVE

Moderna looks to price COVID-19 vaccine at $50-$60 per course

Shines spotlight on pricing strategies for potential vaccines

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links